期刊论文详细信息
BMC Musculoskeletal Disorders
In vivo experimental intervertebral disc degeneration induced by bleomycin in the rhesus monkey
Shaoyu Liu2  Wenfang Chen1  Haixing Sun3  Manman Gao2  Xuenong Zou2  Shangbin Cui2  Ximin Pan3  Le Wang2  Zhiyu Zhou4  Rui Zhong2  Fuxin Wei2 
[1] Department of Pathology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;Department of Spine Surgery, the First Affiliated Hospital and Orthopedic Research Institute of Sun Yat-sen University, Guangzhou, China;Department of Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;The medical school of Shenzhen University, Shenzhen, China
关键词: Rhesus monkey;    Magnetic resonance imaging;    Animal model;    Bleomycin;    Intervertebral disc degeneration;   
Others  :  1121972
DOI  :  10.1186/1471-2474-15-340
 received in 2014-06-15, accepted in 2014-10-03,  发布年份 2014
PDF
【 摘 要 】

Background

Recently, biological therapies for early intervention of degenerative disc disease have been introduced and developed; however, a functional animal model that mimics slowly progressive disc degeneration of humans does not exist. The objective of this study was to establish a slowly progressive and reproducible intervertebral disc (IVD) degeneration model.

Methods

The subchondral bone adjacent to the lumbar IVDs (L3/4 and L5/6) of ten rhesus monkeys was randomly injected with 4 ml bleomycin solution (1.5 mg/ml), or 4 ml phosphate buffer saline (PBS) per segment as control, respectively. The degenerative process was investigated by using radiography and T1ρ MR imaging at 1, 3, 6, 9, 12 and 15 months postoperatively. Histological scoring, Sulfated Glycosaminoglycans (GAGs) analysis and real-time PCR were performed at 15 months. The correlation between histological score, GAGs and T1ρ values were also analyzed.

Results

The results showed that the mean T1ρ values of nucleus pulposus (NP) and annulus fibrosus (AF) in the bleomycin group significantly decreased after 3 and 6 months respectively, followed by slowly decrease until at 15 months. At 15 months, the histological scores was significantly higher, and the GAGs of NP was significantly lower in the bleomycin group, compared with the control group (P < 0.05). The results of real-time PCR revealed a significant increase in matrix metalloprotease (MMP)-3, A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5, tumor necrosis factor α, interleukin-1β, interleukin-6 expressions, transforming growth factor (TGF-β1) and marked reduction in aggrecan, type II collagen, von willebrand factor (vWF) expressions at the mRNA levels in the bleomycin group. Spearman correlation analysis showed a strong positive correlation between GAGs and T1ρ values of NP (r =0.740, P < 0.01), and a significant inverse correlation between histological score and T1ρ values of NP and AF (r = -0.761, r = -0.729, respectively, P < 0.01).

Conclusions

Injection of bleomycin into the subchondral bone adjacent to the lumbar IVDs of rhesus monkeys can results in mild, slowly progressive disc degeneration, which mimics the onset of human disc degeneration. T1ρ MR imaging is an effective and noninvasive technique for assessment of early stage disc degeneration.

【 授权许可】

   
2014 Wei et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150213020743359.pdf 2644KB PDF download
Figure 7. 39KB Image download
Figure 6. 58KB Image download
Figure 5. 66KB Image download
Figure 4. 67KB Image download
Figure 3. 111KB Image download
Figure 2. 53KB Image download
Figure 1. 83KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】
  • [1]Wang C, Gonzales S, Levene H, Gu W, Huang CY: Energy metabolism of intervertebral disc under mechanical loading. J Orthop Res 2013, 3:1733-1738.
  • [2]Hughes SP, Fremont AJ, Hukins DW, McGregor AH, Roberts S: The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J Bone Joint Surg Br 2012, 94:1298-1304.
  • [3]Bergknut N, Rutges JP, Kranenburg HJ, Smolders LA, Hagman R, Smidt HJ, Lagerstedt AS, Penning LC, Voorhout G, Hazewinkel HA, Grinwis GC, Creemers LB, Meij BP, Dhert WJ: The dog as an animal model for intervertebral disc degeneration? Spine (Phila Pa 1976) 2012, 37:351-358.
  • [4]Masuda K, Aota Y, Muehleman C, Imai Y, Okuma M, Thonar EJ, Andersson GB, An HS: A novel rabbit model of mild, reproducible disc degeneration by an annulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine (Phila Pa 1976) 2005, 30:5-14.
  • [5]Xia M, Zhu Y: Fibronectin fragment activation of ERK increasing integrin α₅ and β₁ subunit expression to degenerate nucleus pulposus cells. J Orthop Res 2011, 29:556-561.
  • [6]Haschtmann D, Stoyanov JV, Gédet P, Gédet P, Ferguson SJ: Vertebral endplate trauma induces disc cell apoptosis and promotes organ degeneration in vitro. Eur Spine J 2008, 17:289-299.
  • [7]Grunhagen T, Wilde G, Soukane DM, Shirazi-Adl SA, Urban JP: Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am 2006, 88(suppl 2):30-35.
  • [8]Hassan Y, Osman AK, Altyeb A: Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection. Ann Plast Surg 2013, 70:70-73.
  • [9]Pienaar C, Graham R, Geldenhuys S, Hudson DA: Intralesional bleomycin for the treatment of hemangiomas. Plast Reconstr Surg 2006, 117:221-226.
  • [10]Wang C, Liu J, Pan W, Wang X, Gao Q, Hou S: Pingyangmycin loaded bovine serum albumin microspheres for chemoembolization therapy–in vitro and in vivo studies. Int J Pharm 2008, 351:219-226.
  • [11]Johannessen W, Auerbach JD, Wheaton AJ, Kurji A, Borthakur A, Reddy R, Elliott DM: Assessment of human disc degeneration and proteoglycan content using T1rhoweighted magnetic resonance imaging. Spine (Phila Pa 1976) 2006, 31:1253-1257.
  • [12]Blumenkrantz G, Zuo J, Li X, Kornak J, Link TM, Majumdar S: In vivo 3.0-tesla magnetic resonance T1rho and T2 relaxation mapping in subjects with intervertebral disc degeneration and clinical symptoms. Magn Reson Med 2010, 63:1193-1200.
  • [13]Duncan AE, Colman RJ, Kramer PA: Sex differences in spinal osteoarthritis in humans and rhesus monkeys (Macaca mulatta). Spine (Phila Pa 1976) 2012, 37:915-922.
  • [14]Lü DS, Shono Y, Oda I, Abumi K, Kaneda K: Effects of chondroitinase ABC and chymopapain on spinal motion segment biomechanics. An in vivo biomechanical, radiologic, and histologic canine study. Spine (Phila Pa 1976) 1997, 22:1828-1834.
  • [15]Hoogendoorn RJ, Wuisman PI, Smit TH, Everts VE, Helder MN: Experimental intervertebral disc degeneration induced by chondroitinase ABC in the goat. Spine (Phila Pa 1976) 2007, 32:1816-1825.
  • [16]Zhou Z, Jiang B, Zhou Z, Pan X, Sun H, Huang B, Liang T, Ringgaard S, Zou X: Intervertebral disk degeneration: T1ρ MR imaging of human and animal models. Radiology 2013, 268:492-500.
  • [17]Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177.
  • [18]Wang SZ, Rui YF, Tan Q, Wang C: Enhancing intervertebral disc repair and regeneration through biology: platelet-rich plasma as an alternative strategy. Arthritis Res Ther 2013, 15:220. BioMed Central Full Text
  • [19]Benneker LM, Andersson G, Iatridis JC, Sakai D, Härtl R, Ito K, Grad S: Cell therapy for intervertebral disc repair: advancing cell therapy from bench to clinics. Eur Cell Mater 2014, 27:5-11.
  • [20]Ren S, Liu Y, Ma J, Liu Y, Diao Z, Yang D, Zhang X, Xi Y, Hu Y: Treatment of rabbit intervertebral disc degeneration with co-transfection by adeno-associated virus-mediated SOX9 and osteogenic protein-1 double genes in vivo. Int J Mol Med 2013, 32:1063-1068.
  • [21]Xi Y, Kong J, Liu Y, Wang Z, Ren S, Diao Z, Hu Y: Minimally invasive induction of an early lumbar disc degeneration model in rhesus monkeys. Spine (Phila Pa 1976) 2013, 38:E579-E586.
  • [22]Rodriguez AG, Slichter CK, Acosta FL, Rodriguez-Soto AE, Burghardt AJ, Majumdar S, Lotz JC: Human disc nucleus properties and vertebral endplate permeability. Spine (Phila Pa 1976) 2011, 36:512-520.
  • [23]Bibby SR, Fairbank JC, Urban MR, Urban JP: Cell viability in scoliotic discs in relation to disc deformity and nutrient levels. Spine (Phila Pa 1976) 2002, 27:2220-2228.
  • [24]Anderson DG, Tannoury C: Molecular pathogenic factors in symptomatic disc degeneration. Spine J 2005, 5(6 suppl):260S-266S.
  • [25]Hirata H, Yurube T, Kakutani K, Maeno K, Takada T, Yamamoto J, Kurakawa T, Akisue T, Kuroda R, Kurosaka M, Nishida K: A rat tail temporary static compression model reproduces different stages of intervertebral disc degeneration with decreased notochordal cell phenotype. J Orthop Res 2014, 32:455-463.
  • [26]Cs-Szabo G, Ragasa-San Juan D, Turumella V, Masuda K, Thonar EJ, An HS: Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration. Spine (Phila Pa 1976) 2002, 27:2212-2219.
  • [27]Weiler C, Nerlich AG, Zipperer J, Bachmeier BE, Boos N: SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J 2002, 2002(11):308-320.
  • [28]Millward-Sadler SJ, Costello PW, Freemont AJ, Hoyland JA: Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 2009, 11:R65. BioMed Central Full Text
  • [29]Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M, Boos N: Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann N Y Acad Sci 2007, 1096:44-54.
  • [30]Hoyland JA, Le Maitre C, Freemont AJ: Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford) 2008, 47:809-814.
  • [31]Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM: Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002, 84:196-201.
  • [32]Magalhães J, Ascensão A, Soares JM, Ferreira R, Neuparth MJ, Marques F, Duarte JA: Acute and severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse skeletal muscle. J Appl Physiol (1985) 2005, 99:1247-1253.
  • [33]Cervellati F, Cervellati C, Romani A, Cremonini E, Sticozzi C, Belmonte G, Pessina F, Valacchi G: Hypoxia induces cell damage via oxidative stress in retinal epithelial cells. Free Radic Res 2014, 48:303-312.
  • [34]Guehring T, Wilde G, Sumner M, Grünhagen T, Karney GB, Tirlapur UK, Urban JP: Notochordal intervertebral disc cells: sensitivity to nutrient deprivation. Arthritis Rheum 2009, 60:1026-1034.
  • [35]Thompson JP, Oegema TR Jr, Bradford DS: Stimulation of mature canine intervertebral disc by growth factors. Spine (Phila Pa 1976) 1991, 16:253-260.
  • [36]Lee S, Moon CS, Sul D, Lee J, Bae M, Hong Y, Lee M, Choi S, Derby R, Kim BJ, Kim J, Yoon JS, Wolfer L, Kim J, Wang J, Hwang SW, Lee SH: Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem 2009, 42:1504-1511.
  • [37]Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, Goumans MJ, van den Berg WB, van der Kraan PM: Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 2009, 182:7937-7945.
  • [38]Yamanishi Y, Boyle DL, Clark M, Maki RA, Tortorella MD, Arner EC, Firestein GS: Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 2002, 168:1405-1412.
  • [39]Heathfield SK, Le Maitre CL, Hoyland JA: Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration. Arthritis Res Ther 2008, 10:R87. BioMed Central Full Text
  • [40]Smolders LA, Meij BP, Onis D, Riemers FM, Bergknut N, Wubbolts R, Grinwis GC, Houweling M, Groot Koerkamp MJ, van Leenen D, Holstege FC, Hazewinkel HA, Creemers LB, Penning LC, Tryfonidou MA: Gene expression profiling of early intervertebral disc degeneration reveals a down-regulation of canonical Wnt signaling and caveolin-1 expression: implications for development of regenerative strategies. Arthritis Res Ther 2013, 15:R23. BioMed Central Full Text
  • [41]Odajima N, Betsuyaku T, Nasuhara Y, Nishimura M: Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem 2007, 55:899-909.
  • [42]Battié MC, Videman T: Lumbar disc degeneration: epidemiology and genetics. J Bone Joint Surg Am 2006, 88(suppl 2):3-9.
  文献评价指标  
  下载次数:53次 浏览次数:14次